The incidence of bone metastasis after early-stage breast cancer in Canada

Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial

(2015) Michael Gnant et al.   LANCET

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials

(2015)   LANCET

RANKL expression in normal and malignant breast tissue responds to progesterone and is up-regulated during the luteal phase

(2014) Hong Hu et al.   BREAST CANCER RESEARCH AND TREATMENT

Incidence of bone metastases and survival after a diagnosis of bone metastases in breast cancer patients

(2014) M. Harries et al.   Cancer Epidemiology

Abstract OT2-3-03: Denosumab versus placebo as adjuvant treatment for women with early-stage breast cancer at high risk of disease recurrence (D-CARE): An international, randomized, double-blind, placebo-controlled phase 3 clinical trial

(2014) PE Goss et al.   CANCER RESEARCH

Incidence of bone metastases in breast cancer patients in the United Kingdom: Results of a multi-database linkage study using the general practice research database

(2013) Katrina Wilcox Hagberg et al.   Cancer Epidemiology

Progesterone/RANKL Is a Major Regulatory Axis in the Human Breast

(2013) T. Tanos et al.   Science Translational Medicine

Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid

(2013) Roger von Moos et al.   SUPPORTIVE CARE IN CANCER

Bone-Related Complications and Quality of Life in Advanced Breast Cancer: Results from a Randomized Phase III Trial of Denosumab versus Zoledronic Acid

(2012) M. Martin et al.   CLINICAL CANCER RESEARCH

Outcomes of surveillance for contralateral breast cancer in patients less than age 60 at the time of initial diagnosis

(2012) C. Weinstock et al.   Current Oncology

Incidence of bone metastases and skeletal-related events in breast cancer patients: A population-based cohort study in Denmark

(2011) Annette Ø Jensen et al.   BMC CANCER

Mortality following bone metastasis and skeletal-related events among women with breast cancer: a population-based analysis of U.S. Medicare beneficiaries, 1999–2006

(2011) Nalini Sathiakumar et al.   BREAST CANCER RESEARCH AND TREATMENT

From the ranks of mammary progesterone mediators, RANKL takes the spotlight

(2011) Rodrigo Fernandez-Valdivia et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study

(2010) Alison T. Stopeck et al.   JOURNAL OF CLINICAL ONCOLOGY

Patterns of relapse in breast cancer: changes over time

(2009) Rinat Yerushalmi et al.   BREAST CANCER RESEARCH AND TREATMENT